{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670318916648704.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1111/j.1365-2559.2009.03300.x"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2559.2009.03300.x"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2559.2009.03300.x"}},{"identifier":{"@type":"PMID","@value":"19635099"}}],"dc:title":[{"@value":"L‐type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non‐small cell lung cancer"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p><jats:bold>Aim: </jats:bold> To evaluate the prognostic value of L‐type amino acid transporter 1 (LAT1) in patients with stage I non‐small cell lung cancer (NSCLC).</jats:p><jats:p><jats:bold>Methods and results: </jats:bold> A total of 282 consecutive patients with completely resected pathological stage I NSCLC were retrospectively reviewed. Expression of LAT1 and proliferative activity, as determined by the Ki67 labelling index, were also evaluated immunohistochemically and correlated with the prognosis of patients after complete resection of the tumour. LAT1 expression was positive in 114 patients (40%) [19% of adenocarcinoma (36 of 186 patients), 83% of squamous cell carcinoma (73 of 88 patients) and 63% of large cell carcinoma (five of eight patients)]. There was a significant correlation between LAT1 expression and Ki67 labelling index (γ = 0.6935, <jats:italic>P</jats:italic> < 0.001). LAT1 expression was significantly associated with gender, disease stage and pathological features. The 5‐year survival rate of LAT1+ patients (69.1%) was significantly worse than that of LAT1− patients (89.4%; <jats:italic>P</jats:italic> < 0.001). Multivariate analysis confirmed that positive expression of LAT1 was an independent factor for predicting a poor prognosis.</jats:p><jats:p><jats:bold>Conclusion: </jats:bold> LAT1 expression is a promising pathological factor for predicting the prognosis in patients with resectable stage I NSCLC.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670318916648713","@type":"Researcher","foaf:name":[{"@value":"Hisao Imai"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318916648706","@type":"Researcher","foaf:name":[{"@value":"Kyoichi Kaira"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751139377920","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"40292586"},{"@type":"NRID","@value":"1000040292586"},{"@type":"NRID","@value":"9000004245295"},{"@type":"NRID","@value":"9000004687081"},{"@type":"NRID","@value":"9000003682498"},{"@type":"NRID","@value":"9000241550191"},{"@type":"NRID","@value":"9000391986107"},{"@type":"NRID","@value":"9000009047068"},{"@type":"NRID","@value":"9000019162800"},{"@type":"NRID","@value":"9000253501382"},{"@type":"NRID","@value":"9000010073352"},{"@type":"NRID","@value":"9000256746848"},{"@type":"NRID","@value":"9000256745867"},{"@type":"NRID","@value":"9000404245787"},{"@type":"NRID","@value":"9000023487669"},{"@type":"NRID","@value":"9000021417413"},{"@type":"NRID","@value":"9000000695005"},{"@type":"NRID","@value":"9000021546384"},{"@type":"NRID","@value":"9000006418134"},{"@type":"NRID","@value":"9000014685417"},{"@type":"NRID","@value":"9000256746225"},{"@type":"NRID","@value":"9000000686033"},{"@type":"NRID","@value":"9000238911846"},{"@type":"NRID","@value":"9000238911845"},{"@type":"NRID","@value":"9000238911844"},{"@type":"NRID","@value":"9000018839966"},{"@type":"NRID","@value":"9000399558009"},{"@type":"NRID","@value":"9000001893785"},{"@type":"NRID","@value":"9000319052700"},{"@type":"NRID","@value":"9000014225653"},{"@type":"NRID","@value":"9000252885019"},{"@type":"NRID","@value":"9000256633473"},{"@type":"NRID","@value":"9000018841186"},{"@type":"NRID","@value":"9000253501420"},{"@type":"NRID","@value":"9000253662322"},{"@type":"NRID","@value":"9000398613355"},{"@type":"NRID","@value":"9000001782102"},{"@type":"NRID","@value":"9000256743200"},{"@type":"NRID","@value":"9000018908950"},{"@type":"NRID","@value":"9000018841565"},{"@type":"NRID","@value":"9000257691646"},{"@type":"NRID","@value":"9000020801399"},{"@type":"NRID","@value":"9000022066164"},{"@type":"NRID","@value":"9000021508589"},{"@type":"NRID","@value":"9000020792891"},{"@type":"NRID","@value":"9000323296408"},{"@type":"NRID","@value":"9000415219527"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0098320"}],"foaf:name":[{"@value":"Noboru Oriuchi"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318916648711","@type":"Researcher","foaf:name":[{"@value":"Noriko Yanagitani"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318916648704","@type":"Researcher","foaf:name":[{"@value":"Noriaki Sunaga"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318916648708","@type":"Researcher","foaf:name":[{"@value":"Tamotsu Ishizuka"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318916648707","@type":"Researcher","foaf:name":[{"@value":"Yoshikatsu Kanai"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318916648709","@type":"Researcher","foaf:name":[{"@value":"Hitoshi Endou"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318916648710","@type":"Researcher","foaf:name":[{"@value":"Takashi Nakajima"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670318916648712","@type":"Researcher","foaf:name":[{"@value":"Masatomo Mori"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03090167"},{"@type":"EISSN","@value":"13652559"}],"prism:publicationName":[{"@value":"Histopathology"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2009-06","prism:volume":"54","prism:number":"7","prism:startingPage":"804","prism:endingPage":"813"},"reviewed":"false","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2559.2009.03300.x"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2559.2009.03300.x"}],"createdAt":"2009-06-01","modifiedAt":"2023-10-13","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Lung%20Neoplasms","dc:title":"Lung Neoplasms"},{"@id":"https://cir.nii.ac.jp/all?q=Adolescent","dc:title":"Adolescent"},{"@id":"https://cir.nii.ac.jp/all?q=Kaplan-Meier%20Estimate","dc:title":"Kaplan-Meier Estimate"},{"@id":"https://cir.nii.ac.jp/all?q=Adenocarcinoma","dc:title":"Adenocarcinoma"},{"@id":"https://cir.nii.ac.jp/all?q=Large%20Neutral%20Amino%20Acid-Transporter%201","dc:title":"Large Neutral Amino Acid-Transporter 1"},{"@id":"https://cir.nii.ac.jp/all?q=Young%20Adult","dc:title":"Young Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Carcinoma,%20Non-Small-Cell%20Lung","dc:title":"Carcinoma, Non-Small-Cell Lung"},{"@id":"https://cir.nii.ac.jp/all?q=Biomarkers,%20Tumor","dc:title":"Biomarkers, Tumor"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Cell%20Proliferation","dc:title":"Cell Proliferation"},{"@id":"https://cir.nii.ac.jp/all?q=Neoplasm%20Staging","dc:title":"Neoplasm Staging"},{"@id":"https://cir.nii.ac.jp/all?q=Aged,%2080%20and%20over","dc:title":"Aged, 80 and over"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Prognosis","dc:title":"Prognosis"},{"@id":"https://cir.nii.ac.jp/all?q=Immunohistochemistry","dc:title":"Immunohistochemistry"},{"@id":"https://cir.nii.ac.jp/all?q=Ki-67%20Antigen","dc:title":"Ki-67 Antigen"},{"@id":"https://cir.nii.ac.jp/all?q=Multivariate%20Analysis","dc:title":"Multivariate Analysis"},{"@id":"https://cir.nii.ac.jp/all?q=Carcinoma,%20Squamous%20Cell","dc:title":"Carcinoma, Squamous Cell"},{"@id":"https://cir.nii.ac.jp/all?q=Carcinoma,%20Large%20Cell","dc:title":"Carcinoma, Large Cell"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002218973281408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565170451504896","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"<sup>18</sup>F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185768580480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"L‐type amino acid transporter‐1 and <scp>CD</scp>98 expression in bone and soft tissue tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118740828928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846641064122368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Expression of L-type amino acid transporter 1 in various skin lesions"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643109349248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Correlation of L‐type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1111/j.1365-2559.2009.03300.x"},{"@type":"OPENAIRE","@value":"doi_dedup___::263a92f9624b7e2608e2205b9f86c74a"},{"@type":"CROSSREF","@value":"10.1186/1472-6890-12-4_references_DOI_Usm7BDL9QCQTwPQwSctDfXwk44P"},{"@type":"CROSSREF","@value":"10.1016/j.prp.2014.05.001_references_DOI_Usm7BDL9QCQTwPQwSctDfXwk44P"},{"@type":"CROSSREF","@value":"10.3109/00016489.2014.969385_references_DOI_Usm7BDL9QCQTwPQwSctDfXwk44P"},{"@type":"CROSSREF","@value":"10.1111/pin.12323_references_DOI_Usm7BDL9QCQTwPQwSctDfXwk44P"},{"@type":"CROSSREF","@value":"10.1016/j.pharmthera.2021.107964_references_DOI_Usm7BDL9QCQTwPQwSctDfXwk44P"},{"@type":"CROSSREF","@value":"10.1111/j.1349-7006.2011.02151.x_references_DOI_Usm7BDL9QCQTwPQwSctDfXwk44P"}]}